Medicus Pharma Ltd. (MDCX)
0.26
-0.01
(-4.34%)
USD |
NASDAQ |
Aug 24, 16:00
0.256
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Enterprise Value : 20.94M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.94M |
| August 20, 2026 | 20.96M |
| August 19, 2026 | 20.50M |
| August 18, 2026 | 20.42M |
| August 17, 2026 | 20.23M |
| August 14, 2026 | 21.44M |
| August 13, 2026 | 25.88M |
| August 12, 2026 | 24.50M |
| August 11, 2026 | 25.39M |
| August 10, 2026 | 23.93M |
| August 07, 2026 | 22.61M |
| August 06, 2026 | 23.09M |
| August 05, 2026 | 22.44M |
| August 04, 2026 | 22.87M |
| August 03, 2026 | 22.69M |
| July 31, 2026 | 21.14M |
| July 30, 2026 | 20.38M |
| July 29, 2026 | 20.83M |
| July 28, 2026 | 21.43M |
| July 27, 2026 | 23.73M |
| July 24, 2026 | 26.84M |
| July 23, 2026 | 27.70M |
| July 22, 2026 | 27.12M |
| July 21, 2026 | 27.91M |
| July 20, 2026 | 25.88M |
| Date | Value |
|---|---|
| July 17, 2026 | 27.19M |
| July 16, 2026 | 29.01M |
| July 15, 2026 | 25.55M |
| July 14, 2026 | 26.47M |
| July 13, 2026 | 26.98M |
| July 10, 2026 | 29.11M |
| July 09, 2026 | 30.00M |
| July 08, 2026 | 30.36M |
| July 07, 2026 | 31.06M |
| July 06, 2026 | 32.26M |
| July 02, 2026 | 29.63M |
| July 01, 2026 | 28.65M |
| June 30, 2026 | 31.44M |
| June 29, 2026 | 16.84M |
| June 26, 2026 | 15.65M |
| June 25, 2026 | 15.13M |
| June 24, 2026 | 14.34M |
| June 23, 2026 | 15.53M |
| June 22, 2026 | 15.29M |
| June 18, 2026 | 15.63M |
| June 17, 2026 | 11.39M |
| June 16, 2026 | 10.72M |
| June 15, 2026 | 10.13M |
| June 12, 2026 | 10.83M |
| June 11, 2026 | 10.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.834B |
| enGene Therapeutics, Inc. | -105.95M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 4.955B |
| Psyence Biomedical Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.440M |
| Total Expenses (Quarterly) | 8.392M |
| EPS Diluted (Quarterly) | -0.1524 |
| Earnings Yield | -623.3% |
| Normalized Earnings Yield | -524.15 |